RDC-3317 Aripiprazole lauroxil cas 1259305-29-7
Price:
Negotiable
MOQ:
1g
Delivery Time:
Negotiable
Brand:
Crene
Product Description
Chemical Information
| Product name:RDC-3317 Aripiprazole lauroxil | Purity:98% min |
| CAS NO:1259305-29-7 | Solubility: |
| Molecular Formula:C36H51Cl2N3O4 | Package:Package according to customer requirements |
| Molecular Weight:660.714 | Storage:Store at -20℃ |
Remarks
Aripiprazole lauroxil, aslo known as RDC 3317, is a long-acting injectable atypical antipsychotic. It is an N-acyloxymethyl prodrug of aripiprazole that is administered via intramuscular injection once every four to six weeks for the treatment of schizophrenia.
References
1: Aggarwal A, Gopalakrishna G, Lauriello J. Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents. Clin Schizophr Relat Psychoses. 2016 Spring;10(1):58-63. doi: 10.3371/csrp.AGGA.040316. PubMed PMID: 27074333.
2: Fellner C. Pharmaceutical Approval Update. P T. 2015 Dec;40(12):807-8. PubMed PMID: 26681901; PubMed Central PMCID: PMC4671464.
Similar Products
Get in Touch
Have questions about our products or want to discuss a custom order? Our team is ready to help you.
Company
Taizhou Crene Biotechnology Co., Ltd.
Location
Add: Economic Developed Zone of Taizhou Zhejiang China.